Pharma's Zika Pursuit: All About The Profits?
This article was originally published in Scrip
Executive Summary
When the National Institute of Allergy and Infectious Diseases (NIAID) developed an experimental West Nile virus vaccine, it struggled to find an industry partner to take the product through advanced development and to the marketplace, despite a great public health need, said the agency's director, Anthony Fauci.